American International Group’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,873
| Closed | -$36.5K | – | 2165 |
|
|
2024
Q1 | $36.5K | Sell |
1,873
-74
| -4% | -$1.44K | ﹤0.01% | 2849 |
|
|
2023
Q4 | $40.3K | Buy |
1,947
+15
| +0.8% | +$310 | ﹤0.01% | 2862 |
|
|
2023
Q3 | $61.4K | Buy |
1,932
+69
| +4% | +$2.19K | ﹤0.01% | 2764 |
|
|
2023
Q2 | $62.6K | Buy |
+1,863
| New | +$62.6K | ﹤0.01% | 2821 |
|
|
2022
Q2 | – | Sell |
-1,523
| Closed | -$56K | – | 3237 |
|
|
2022
Q1 | $56K | Sell |
1,523
-108
| -7% | -$3.97K | ﹤0.01% | 2809 |
|
|
2021
Q4 | $159K | Sell |
1,631
-26
| -2% | -$2.54K | ﹤0.01% | 2500 |
|
|
2021
Q3 | $207K | Sell |
1,657
-11
| -0.7% | -$1.37K | ﹤0.01% | 2415 |
|
|
2021
Q2 | $209 | Buy |
1,668
+351
| +27% | +$44 | ﹤0.01% | 2477 |
|
|
2021
Q1 | $179 | Buy |
1,317
+3
| +0.2% | – | ﹤0.01% | 2424 |
|
|
2020
Q4 | $119 | Sell |
1,314
-38
| -3% | -$3 | ﹤0.01% | 2568 |
|
|
2020
Q3 | $101K | Sell |
1,352
-30
| -2% | -$2.24K | ﹤0.01% | 2534 |
|
|
2020
Q2 | $118K | Buy |
+1,382
| New | +$118K | ﹤0.01% | 2423 |
|
|
2019
Q2 | – | Sell |
-727
| Closed | -$52K | – | 3147 |
|
|
2019
Q1 | $52K | Buy |
727
+332
| +84% | +$23.7K | ﹤0.01% | 2864 |
|
|
2018
Q4 | $32K | Sell |
395
-3
| -0.8% | -$243 | ﹤0.01% | 2971 |
|
|
2018
Q3 | $186K | Buy |
398
+7
| +2% | +$3.27K | ﹤0.01% | 2469 |
|
|
2018
Q2 | $155K | Buy |
391
+91
| +30% | +$36.1K | ﹤0.01% | 2517 |
|
|
2018
Q1 | $92K | Sell |
300
-13
| -4% | -$3.99K | ﹤0.01% | 2698 |
|
|
2017
Q4 | $92K | Buy |
313
+51
| +19% | +$15K | ﹤0.01% | 2764 |
|
|
2017
Q3 | $143K | Buy |
262
+20
| +8% | +$10.9K | ﹤0.01% | 2469 |
|
|
2017
Q2 | $144K | Buy |
242
+138
| +133% | +$82.1K | ﹤0.01% | 2485 |
|
|
2017
Q1 | $45K | Buy |
+104
| New | +$45K | ﹤0.01% | 2863 |
|